tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Coherus Biosciences: Buy Rating Affirmed Amid Strong Sales Alignment and Promising Pipeline Developments
PremiumRatingsCoherus Biosciences: Buy Rating Affirmed Amid Strong Sales Alignment and Promising Pipeline Developments
2M ago
Coherus Biosciences: Promising Growth and Strategic Positioning Justify Buy Rating
Premium
Ratings
Coherus Biosciences: Promising Growth and Strategic Positioning Justify Buy Rating
2M ago
Coherus Oncology Reports Strong Q2 2025 Growth
Premium
Company Announcements
Coherus Oncology Reports Strong Q2 2025 Growth
2M ago
Coherus Biosciences Rebrands to Coherus Oncology
PremiumCompany AnnouncementsCoherus Biosciences Rebrands to Coherus Oncology
4M ago
Coherus Biosciences completes transformation to Coherus Oncology
Premium
The Fly
Coherus Biosciences completes transformation to Coherus Oncology
4M ago
Coherus Biosciences announces clinical collaboration with STORM Therapeutics
Premium
The Fly
Coherus Biosciences announces clinical collaboration with STORM Therapeutics
4M ago
Coherus BioSciences: Q1 2025 Financial Highlights and Strategic Shift
PremiumCompany AnnouncementsCoherus BioSciences: Q1 2025 Financial Highlights and Strategic Shift
5M ago
CHRS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CHRS Upcoming Earnings Report: What to Expect?
5M ago
Promising Clinical Data and Strategic Expansion Justify Buy Rating for Coherus Biosciences
Premium
Ratings
Promising Clinical Data and Strategic Expansion Justify Buy Rating for Coherus Biosciences
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100